
Akt3 degrader 1
CAS No. 2836342-69-7
Akt3 degrader 1( —— )
Catalog No. M36618 CAS No. 2836342-69-7
Akt3 degrader 1 is a specific Akt3 degrader with anticancer and antiproliferative activity that inhibits tumor growth in mice.Akt3 degrader 1 is used in the study of non-small cell lung cancer and pancreatic cancer.
Purity : >98% (HPLC)






Size | Price / USD | Stock | Quantity |
2MG | 296 | Get Quote |
![]() ![]() |
5MG | 459 | Get Quote |
![]() ![]() |
10MG | 657 | Get Quote |
![]() ![]() |
25MG | 994 | Get Quote |
![]() ![]() |
50MG | 1371 | Get Quote |
![]() ![]() |
100MG | 1764 | Get Quote |
![]() ![]() |
500MG | Get Quote | Get Quote |
![]() ![]() |
1G | Get Quote | Get Quote |
![]() ![]() |
Biological Information
-
Product NameAkt3 degrader 1
-
NoteResearch use only, not for human use.
-
Brief DescriptionAkt3 degrader 1 is a specific Akt3 degrader with anticancer and antiproliferative activity that inhibits tumor growth in mice.Akt3 degrader 1 is used in the study of non-small cell lung cancer and pancreatic cancer.
-
DescriptionAkt3 degrader 1 (compound 12l) is a selective Akt3 degrader that overcomes Osimertinib (HY-15772)-induced resistance in H1975OR NSCLC cells. Akt3 degrader 1 also has anti-proliferative activity and significantly inhibits tumour growth in mice. Akt3 degrader 1 can be used in the study of drug-resistant non-small cell lung cancer.
-
In VitroAkt3 degrader 1 (0.001-100 μM; 24 h) shows antiproliferative effects on H1975OR cells with an IC50 of 0.972 μM.Akt3 degrader 1 (1.6, 8, 40, 200, 1000 nM; 24 h) induces degradation of Akt3 through the ubiquitin proteasome-mediated proteolysis process in NSCLC cell lines.Akt3 degrader 1 (10, 100 nM) selectively and dose-dependently degrades exogenous PH domain-only Akt3 protein but not the Akt3 del PH mutant in H1975OR cells.Akt3 degrader 1 overcomes osimertinib-induced resistance in H1975OR NSCLC cells via disrupting the noncatalytic functions of Akt3.Cell Proliferation Assay Cell Line:H1975OR cells Concentration:0.001-100 μM Incubation Time:24 h Result:Inhibited growth of H1975OR cells with an IC50 of 0.972 μM.Western Blot Analysis Cell Line:A549, HCC827, H1975, H1975OR, PC9, H1299, and H460 cells Concentration:1.6, 8, 40, 200, 1000 nM Incubation Time:24 h Result:Selectively induced Akt3 degradation in all of these cell lines in a dose-dependent manner, whereas had minimal influence on Akt1 and Akt2 protein levels.
-
In VivoAkt3 degrader 1 (10, 20 mg/kg; i.p.; every 3 days for 5 weeks) induces significant tumor growth inhibition (TGI) with an approximately TGI value of 75% in mice.Animal Model:NOD-SCID-IL2Rg-/-(NSI) mice (H1975OR xenograft model).Dosage:10, 20 mg/kg Administration:Intraperitoneal administration; every 3 days for 5 weeks Result:Inhibited tumor growth without causing obvious body weight loss or other signs of toxicity.
-
Synonyms——
-
PathwayCytoskeleton/Cell Adhesion Molecules
-
TargetAkt
-
RecptorAkt
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number2836342-69-7
-
Formula Weight885.19
-
Molecular FormulaC53H72N8O4
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESO=C1C=C(C=2C=NC(=NC2N1C=3C=CC=C(C3)NC(=O)C4CC4)NC5=CC=C(C=C5OC)N6CCN(CC6)CCCCCCCCCCCCNC(=O)CC78CC9CC(CC(C9)C7)C8)C
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Xu F, et al. Discovery of Isoform-Selective Akt3 Degraders Overcoming Osimertinib-Induced Resistance in Non-Small Cell Lung Cancer Cells. J Med Chem. 2022 Oct 27;65(20):14032-14048. ?
molnova catalog



related products
-
I-CBP112 hydrochlori...
I-CBP112 is a selective inhibitor of the bromodomain-containing transcription factors. I-CBP112 (1 mM) has little activity against other bromodomains.
-
Akt3 degrader 1
Akt3 degrader 1 is a specific Akt3 degrader with anticancer and antiproliferative activity that inhibits tumor growth in mice.Akt3 degrader 1 is used in the study of non-small cell lung cancer and pancreatic cancer.
-
Cariprazine
Cariprazine is a novel antipsychotic drug candidate that exhibits high affinity for the D3 (Ki=0.085 nM) and D2 (Ki=0.49 nM) receptors, and moderate affinity for the 5-HT1A receptor (Ki=2.6 nM).